FGH BioTech, Inc.
PrivateLast Round
Early Funding
Apr 12, 2023
Total Funding Raised
$1.18M
Company Overview
FGH BioTech, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. It has raised $1.18M.
FGH BioTech, Inc. is a biopharmaceutical company that develops small-molecule drugs targeting SREBP transcription factors for the treatment of metabolic disorders and cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FGH BioTech, Inc. Comparables
Compare FGH BioTech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagimet Biosciences | 66% | |
| Dracen Pharmaceuticals, Inc. | 63% | |
| Lime Therapeutics | 62% |
For institutional investors. Book with your work email.
FGH BioTech, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FGH BioTech, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2023
Raised $6M in early funding.
For institutional investors. Book with your work email.
FGH BioTech, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FGH BioTech, Inc.'s valuation, stock price, and market status.
Is FGH BioTech, Inc. a public or private company?
FGH BioTech, Inc. is a private company.
What is the current stock price of FGH BioTech, Inc.?
FGH BioTech, Inc. is a private company, so its shares have no public market price. Caplight tracks FGH BioTech, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FGH BioTech, Inc. worth (valuation)?
Valuation information for FGH BioTech, Inc. is not publicly available.
Can I buy FGH BioTech, Inc. stock?
FGH BioTech, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FGH BioTech, Inc.'s last funding round?
FGH BioTech, Inc.'s most recent funding round was Early Funding on April 12, 2023.
Who are the main investors in FGH BioTech, Inc.?
Key investors in FGH BioTech, Inc. include National Institutes of Health (NIH).
Will FGH BioTech, Inc. IPO soon?
No public IPO plans have been announced for FGH BioTech, Inc..
How can I track FGH BioTech, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in FGH BioTech, Inc.'s shares on secondary markets.